Breaks Categories: Stock Spotlights

ThursdayJan 04, 2018 11:31 am

CannabisNewsBreaks – DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) Northern Lights Subsidiary Making Strides Toward Sales License

Premium cannabis lifestyle brand DOJA Cannabis Company’s (CSE: DOJA) (OTC: DJACF) wholly owned subsidiary, Northern Lights Marijuana Company, is a Health Canada licensed cannabis producer on the track to gain a Sales License. An article discussing the company reads: “DOJA’s initial cannabis harvest, produced under the Access to Cannabis for Medical Purposes Regulations (ACMPR) license held by its subsidiary, Northern Lights Marijuana Company, will be inspected by Health Canada regulators as the last step before a Sales License can be awarded. Once DOJA passes this major milestone and receives its Sales License, the company can begin selling cannabis and position…

Continue Reading

ThursdayJan 04, 2018 11:19 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Aims to Provide Fully Integrated Solution for Cannabis Companies

Full-service mobile technology provider SinglePoint (OTC: SING) is on a mission to build a fully integrated solution for cannabis businesses to help manage day-to-day operations from beginning to end. An article discussing this reads: “SinglePoint, Inc. (OTC: SING) has been cited by the The Greensheet Online Edition for building a “soup-to-nuts” platform for payment processing in the cryptocurrency and cannabis industries  (http://cnw.fm/9qlqE). The goal, according to Wil Ralston, SING president, is to have a “fully integrated solution for businesses to manage their day-to-day operations from beginning to end.” Greensheet prominently mentioned SinglePoint in a section titled, “Workarounds Emerging.” It detailed…

Continue Reading

WednesdayJan 03, 2018 11:49 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Highlights Hidden Value of Wide-ranging DehydraTECH™ Patent

Based in Kelowna, British Columbia, Canada, food bioscience company Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is a technology disruptor for edible CBD. An article discussing this reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka said in an audio interview with the Uptick Newswire Podcast (http://cnw.fm/Refc4) that the company was not only surprised by how quickly it received its patent for DehydraTECH™; it was also surprised by the broadness of the patent awarded for its utilization in other sectors, which it had expected in 2018 and 2019. The company believes that the new patent has locked up the…

Continue Reading

TuesdayJan 02, 2018 11:33 am

CannabisNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Cannabis-based Eating Disorder Treatment Anticipated for PCT Filing in February

India Globalization Capital (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, has recently developed IGC-506 for the treatment of multiple types of eating disorders in humans, as well as animals in the veterinary market. The company expects to file a Patent Cooperation Treaty (“PCT”) application by February 28, 2018. PCT is an international patent filing effective in numerous foreign countries. An article discussing this reads: “IGC-506 is a combination therapy drug, developed from cannabis-extracts and other compounds, designed to treat multiple types of eating disorders. Cannabinoids are chemical compounds that exert a range…

Continue Reading

FridayDec 29, 2017 12:05 pm

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Prepares to Address Killer Drug Epidemic Through Proposed Merger Agreement

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a letter of intent regarding a proposed merger with Quoin Pharmaceuticals Limited. The two companies intend to work together to address the opioid epidemic plaguing America. An article discussing this reads: “There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed…

Continue Reading

FridayDec 29, 2017 11:57 am

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Positioned for Bright Future Amid Support from Recognized Health Organization

With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) is slated to exploit the ever-growing cannabis market as support of the industry continues to grow among recognized health organizations. An article discussing this reads: “The World Health Organization (“WHO”) officially recommended on December 14, 2017, that the chemical compound cannabidiol (CBD) no longer be internationally scheduled as a controlled substance. WHO has issued a preliminary report that found CBD to be non-addictive and generally safe. ... The wholly-owned subsidiary of Marijuana Company of America Inc. (OTC: MCOA), hempSMART™, Inc. is an affiliate marketing…

Continue Reading

ThursdayDec 28, 2017 11:29 am

CannabisNewsBreaks – AppSwarm, Inc. (SWRM) Has Finger on Pulse of Burgeoning Mobile Gaming Industry

As gaming, and mobile gaming in particular, approaches an expected $110 billion in revenues worldwide this year, developer and publisher AppSwarm (OTC: SWRM) is working to incubate new talent as it acquires apps for all mobile devices. The company also announced the development of a joint roll-out of mobile applications for the purchase of cannabis using bitcoin payment options and blockchain technology, in conjunction with SinglePoint, Inc. (OTC: SING). Article discussing this reads: “The global gaming industry is expected to grow by almost eight percent over 2016 and to generate a total of approximately $110 billion in revenues this year,…

Continue Reading

WednesdayDec 27, 2017 12:16 pm

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Serving Cannabis Industry with Merchant Processing Power

As attention grows in regard to the possibilities for a legal marketplace serving the varied needs of the medical and recreational marijuana industries, Medical Cannabis Payment Solutions (OTC: REFG) is positioning itself to compete in the industry verticals serving cannabis patients and corporate clients. An article discussing this reads: “In response to the need for a private encrypted digital solution, REFG is positioned in the industry as a first-tier merchant processing pioneer. REFG, through subsidiary StateSourced, has launched the first and only comprehensive card processing system of its kind. With considerable investment in market research and product development, the company…

Continue Reading

WednesdayDec 27, 2017 11:55 am

CannabisNewsBreaks – CNBC Publication Highlights SinglePoint, Inc.’s (SING) SingleSeed as Alternative for Cash-only Cannabis Industry

SinglePoint’s (OTC: SING) mobile app SingleSeed is gaining attention thanks to a CNBC article on its ability to help cannabis dispensaries and customers exchange funds through bitcoin. Using debit or credit cards, consumers can make purchases without the need to rely on conventional banks that may be reluctant to transact business with the cannabis industry amid ongoing controversy about federal drug policy. An article discussing this reads: “It was obvious banks didn’t want to handle legal marijuana transactions, … which meant cannabis retailers and consumers were forced to bring cash to the table, and it was apparent that an alternative…

Continue Reading

TuesdayDec 26, 2017 12:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Set to Exploit the Cannabis Industry Utilizing Proprietary Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is well positioned in the booming cannabis industry with its patent-protected technology, DehyraTECH™, which enables a more efficient delivery and absorption of cannabinoids. An article discussing this reads: “Lexaria research and development partnership with the Canadian government’s National Research Council underscores the significance of its unique technology. Results from the endeavor are expected to support accelerating B2B relationships – and not just in the booming cannabis and CBD/hemp oil industry. Much more can be done to enhance and enable delivery of active pharmaceutical ingredients in a wide variety of important health-related fields, offering Lexaria…

Continue Reading